Wells Fargo & Company BIOXCEL THERAPEUTICS INC Transaction History
Wells Fargo & Company
- $468 Billion
- Q2 2025
Number of Shares
16,919
Previous 12,293
37.63%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%